Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICESAMS · Entity 8010 | Director | June 18, 2019 | June 21, 2019 |
| Forian Inc.FORA · Entity 47119 | Director | March 26, 2025 | March 28, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AMERICAN SHARED HOSPITAL SERVICES
Report date June 18, 2019 · Filed June 21, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, No Par ValueSEC Table I · non-derivative | Direct | 87,847 |
Ending reported balance
After 2019-06-18 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2019-06-18 · Exercise / conversion · Acquired 2,000 · Balance 81,847 Row 2 · 2019-06-18 · Exercise / conversion · Acquired 2,000 · Balance 83,847 Row 3 · 2019-06-18 · Exercise / conversion · Acquired 2,000 · Balance 85,847 Row 4 · 2019-06-18 · Exercise / conversion · Acquired 2,000 · Balance 87,847 |
| Stock optionsSEC Table II · derivative / convertible security · Conversion / exercise price $2.16 · Expires 2020-06-10 | Direct | 0 |
Reported balance
After 2019-06-18 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2019-06-18 · Exercise / conversion · Disposed 2,000 · Balance 0 |
| Stock optionsSEC Table II · derivative / convertible security · Conversion / exercise price $2.43 · Expires 2021-06-09 | Direct | 0 |
Reported balance
After 2019-06-18 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2019-06-18 · Exercise / conversion · Disposed 2,000 · Balance 0 |
| Stock optionsSEC Table II · derivative / convertible security · Conversion / exercise price $2.25 · Expires 2023-06-20 | Direct | 0 |
Reported balance
After 2019-06-18 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2019-06-18 · Exercise / conversion · Disposed 2,000 · Balance 0 |
| Stock optionsSEC Table II · derivative / convertible security · Conversion / exercise price $2.68 · Expires 2025-06-13 | Direct | 0 |
Reported balance
After 2019-06-18 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2019-06-18 · Exercise / conversion · Disposed 2,000 · Balance 0 |
Forian Inc.
Report date March 26, 2025 · Filed March 28, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.06 · Expires 2035-03-26 | Direct | 15,000 |
Reported balance
After 2025-03-26 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-03-26 · Grant · Acquired 15,000 · Balance 15,000 F1: The stock option vests in four equal annual installments beginning on March 26, 2026, subject to the Reporting Person's continued service as a non-employee director of the Issuer on each applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The stock option vests in four equal annual installments beginning on March 26, 2026, subject to the Reporting Person's continued service as a non-employee director of the Issuer on each applicable vesting date.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
WebMD Health Corp.
Report date September 15, 2017 · Filed September 15, 2017
Section 16 reporting ended · disclosed 2017-09-15. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2017-09-15 transaction · row 1
1 source rowRow 1 · 2017-09-15 · Other · Disposed 20,689 · Balance 0 F1: Sold in a tender offer made by Diagnosis Merger Sub, Inc., a Delaware Corporation ("Purchaser") and a wholly-owned subsidiary of MH Sub I, LLC, a Delaware limited liability company ("Parent"), to purchase all of the issued and outstanding shares of common stock of WebMD Health Corp., a Delaware corporation ("WebMD"), for $66.50 per share, pursuant to the terms of that certain Agreement and Plan of Merger, dated as of July 24, 2017, by and among WebMD, Purchaser, and Parent (the "Merger Agreement"). |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 0 |
Reported balance
After 2017-09-15 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2017-09-15 · Other · Disposed 935 · Balance 0 F1: Sold in a tender offer made by Diagnosis Merger Sub, Inc., a Delaware Corporation ("Purchaser") and a wholly-owned subsidiary of MH Sub I, LLC, a Delaware limited liability company ("Parent"), to purchase all of the issued and outstanding shares of common stock of WebMD Health Corp., a Delaware corporation ("WebMD"), for $66.50 per share, pursuant to the terms of that certain Agreement and Plan of Merger, dated as of July 24, 2017, by and among WebMD, Purchaser, and Parent (the "Merger Agreement"). |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $38.49 · Expires 2020-01-01 | Direct | 0 |
Reported balance
After 2017-09-15 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2017-09-15 · Disposition to issuer · Disposed 13,200 · Balance 0 F2: On September 15, 2017, the merger transaction (the "Merger") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to completion of the Merger, or that vested upon completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the exercise price of each such option. In connection with the completion of the Merger, each unvested option held by the Reporting Person fully accelerated. The Reporting Person no longer owns any securities issued by WebMD. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $37.55 · Expires 2022-01-01 | Direct | 0 |
Reported balance
After 2017-09-15 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2017-09-15 · Disposition to issuer · Disposed 13,200 · Balance 0 F2: On September 15, 2017, the merger transaction (the "Merger") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to completion of the Merger, or that vested upon completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the exercise price of each such option. In connection with the completion of the Merger, each unvested option held by the Reporting Person fully accelerated. The Reporting Person no longer owns any securities issued by WebMD. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $14.34 · Expires 2023-01-01 | Direct | 0 |
Reported balance
After 2017-09-15 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2017-09-15 · Disposition to issuer · Disposed 6,600 · Balance 0 F2: On September 15, 2017, the merger transaction (the "Merger") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to completion of the Merger, or that vested upon completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the exercise price of each such option. In connection with the completion of the Merger, each unvested option held by the Reporting Person fully accelerated. The Reporting Person no longer owns any securities issued by WebMD. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $39.50 · Expires 2024-01-01 | Direct | 0 |
Reported balance
After 2017-09-15 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2017-09-15 · Disposition to issuer · Disposed 13,200 · Balance 0 F2: On September 15, 2017, the merger transaction (the "Merger") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to completion of the Merger, or that vested upon completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the exercise price of each such option. In connection with the completion of the Merger, each unvested option held by the Reporting Person fully accelerated. The Reporting Person no longer owns any securities issued by WebMD. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $39.55 · Expires 2025-01-01 | Direct | 0 |
Reported balance
After 2017-09-15 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2017-09-15 · Disposition to issuer · Disposed 13,200 · Balance 0 F2: On September 15, 2017, the merger transaction (the "Merger") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to completion of the Merger, or that vested upon completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the exercise price of each such option. In connection with the completion of the Merger, each unvested option held by the Reporting Person fully accelerated. The Reporting Person no longer owns any securities issued by WebMD. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $48.30 · Expires 2026-01-01 | Direct | 0 |
Reported balance
After 2017-09-15 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2017-09-15 · Disposition to issuer · Disposed 13,200 · Balance 0 F2: On September 15, 2017, the merger transaction (the "Merger") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to completion of the Merger, or that vested upon completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the exercise price of each such option. In connection with the completion of the Merger, each unvested option held by the Reporting Person fully accelerated. The Reporting Person no longer owns any securities issued by WebMD. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $49.57 · Expires 2027-01-01 | Direct | 0 |
Reported balance
After 2017-09-15 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2017-09-15 · Disposition to issuer · Disposed 13,200 · Balance 0 F2: On September 15, 2017, the merger transaction (the "Merger") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to completion of the Merger, or that vested upon completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the exercise price of each such option. In connection with the completion of the Merger, each unvested option held by the Reporting Person fully accelerated. The Reporting Person no longer owns any securities issued by WebMD. |
Filing footnotes · ownership attribution and instrument terms
F1: Sold in a tender offer made by Diagnosis Merger Sub, Inc., a Delaware Corporation ("Purchaser") and a wholly-owned subsidiary of MH Sub I, LLC, a Delaware limited liability company ("Parent"), to purchase all of the issued and outstanding shares of common stock of WebMD Health Corp., a Delaware corporation ("WebMD"), for $66.50 per share, pursuant to the terms of that certain Agreement and Plan of Merger, dated as of July 24, 2017, by and among WebMD, Purchaser, and Parent (the "Merger Agreement").
F2: On September 15, 2017, the merger transaction (the "Merger") contemplated by the Merger Agreement was completed and WebMD was acquired by the Purchaser and ceased to be a public company. Pursuant to the Merger Agreement, each option that was vested and exercisable immediately prior to completion of the Merger, or that vested upon completion of the Merger in accordance with its terms, was automatically cancelled in exchange for the right of the holder to receive an amount in cash equal to the excess of $66.50 over the exercise price of each such option. In connection with the completion of the Merger, each unvested option held by the Reporting Person fully accelerated. The Reporting Person no longer owns any securities issued by WebMD.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 06, 2016 Filed Dec 8, 2016 17:34 UTC | WebMD Health Corp. WBMD · Entity 12671 | SaleCommon Stock | 8,000 | $53.37 | $426,960.00 |
DisclosureSEC source: 0000947871-16-001755 · ss22811_4.xml · nonDerivative · entry 1 TROTMAN STANLEY S JR · CIK 0001251638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,209 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.90 to $53.65 inclusive. The reporting person undertakes to provide to WebMD Health Corp., any security holder of WebMD Health Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| November 22, 2016 Filed Nov 23, 2016 18:26 UTC | WebMD Health Corp. WBMD · Entity 12671 | Exercise / conversionStock Option (right to buy) · Derivative | 13,200 | $0.00 Strike: $41.07 | $0.00 |
DisclosureSEC source: 0000947871-16-001716 · ss20684_4.xml · derivative · entry 7 TROTMAN STANLEY S JR · CIK 0001251638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,200 shares Expires 2018-01-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 25% of the shares underlying the option vested on each of the first, second, third and fourth anniversary of the date of grant (fully vested on the 4th anniversary of the grant date). The date of grant was ten years prior to the expiration date. Read SEC document |
| November 22, 2016 Filed Nov 23, 2016 18:26 UTC | WebMD Health Corp. WBMD · Entity 12671 | Exercise / conversionStock Option (right to buy) · Derivative | 13,200 | $0.00 Strike: $40.02 | $0.00 |
DisclosureSEC source: 0000947871-16-001716 · ss20684_4.xml · derivative · entry 6 TROTMAN STANLEY S JR · CIK 0001251638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,200 shares Expires 2017-01-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 25% of the shares underlying the option vested on each of the first, second, third and fourth anniversary of the date of grant (fully vested on the 4th anniversary of the grant date). The date of grant was ten years prior to the expiration date. Read SEC document |
| November 22, 2016 Filed Nov 23, 2016 18:26 UTC | WebMD Health Corp. WBMD · Entity 12671 | Tax withholdingCommon Stock | 10,069 | $53.85 | $542,215.65 |
DisclosureSEC source: 0000947871-16-001716 · ss20684_4.xml · nonDerivative · entry 4 TROTMAN STANLEY S JR · CIK 0001251638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,209 F2 · balance_after: Mr. Trotman received 3,131 shares of WebMD Common Stock upon net share settlement of his exercise of options to purchase 13,200 shares of WebMD Common Stock, with the remaining 10,069 shares being retained by the issuer to pay the exercise price. Read SEC document |
| November 22, 2016 Filed Nov 23, 2016 18:26 UTC | WebMD Health Corp. WBMD · Entity 12671 | Exercise / conversionCommon Stock | 13,200 | $41.07 | $542,124.00 |
DisclosureSEC source: 0000947871-16-001716 · ss20684_4.xml · nonDerivative · entry 3 TROTMAN STANLEY S JR · CIK 0001251638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,278 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 22, 2016 Filed Nov 23, 2016 18:26 UTC | WebMD Health Corp. WBMD · Entity 12671 | Tax withholdingCommon Stock | 9,811 | $53.85 | $528,322.35 |
DisclosureSEC source: 0000947871-16-001716 · ss20684_4.xml · nonDerivative · entry 2 TROTMAN STANLEY S JR · CIK 0001251638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,078 F1 · balance_after: Mr. Trotman received 3,389 shares of WebMD Common Stock upon net share settlement of his exercise of options to purchase 13,200 shares of WebMD Common Stock, with the remaining 9,811 shares being retained by the issuer to pay the exercise price. Read SEC document |
| November 22, 2016 Filed Nov 23, 2016 18:26 UTC | WebMD Health Corp. WBMD · Entity 12671 | Exercise / conversionCommon Stock | 13,200 | $40.02 | $528,264.00 |
DisclosureSEC source: 0000947871-16-001716 · ss20684_4.xml · nonDerivative · entry 1 TROTMAN STANLEY S JR · CIK 0001251638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,889 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 15, 2016 Filed Nov 17, 2016 18:07 UTC | WebMD Health Corp. WBMD · Entity 12671 | GrantCommon Stock | 975 | $53.83 | $52,484.25 |
DisclosureSEC source: 0000947871-16-001697 · ss19901_4.xml · nonDerivative · entry 1 TROTMAN STANLEY S JR · CIK 0001251638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,689 F1 · shares: Payment of annual retainer for services as a non-employee member of the Board of Directors and its committees. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.